Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2011
[Chemotherapy-induced stomatitis and diarrhea]Shigenori Kadowaki, Kensei Yamaguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 20, 2007
[The palliative care in the clinical oncology]Shigenori Kadowaki, Makoto Tahara, Nagahiro Saijo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 2004
[Early onset invasive pulmonary zygomycosis following allogeneic peripheral blood stem cell transplantation in a patient with therapy-related myelodysplastic syndrome]Keiki Kawakami, Yasuyuki Watanabe, Shigenori Kadowaki
Case Reports in Oncology|June 14, 2016
Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to ChemotherapySeiichiro Mitani, Shigenori Kadowaki, Hiroya Taniguchi, et al.
Case Reports in Oncology|May 8, 2014
Durable response of human epidermal growth factor receptor-2-positive gastric adenosquamous carcinoma to trastuzumab-based chemotherapyShigenori Kadowaki, Yasushi Yatabe, Sohei Nitta, et al.
Case Reports in Oncology|May 25, 2019
Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard TherapiesSeiichiro Mitani, Shigenori Kadowaki, Kyoko Kato, et al.
Anticancer Research|December 25, 2016
Platinum-based Doublet Chemotherapy for Advanced Gastric Cancer with Disseminated Intravascular CoagulationKeiji Sugiyama, Yukiya Narita, Shigenori Kadowaki, et al.
Japanese Journal of Clinical Oncology|February 13, 2009
Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in JapanNaomi Kiyota, Makoto Tahara, Shigenori Kadowaki, et al.
Case Reports in Oncology|October 29, 2013
Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic AdenomaShigenori Kadowaki, Yasushi Yatabe, Hitoshi Hirakawa, et al.
International Journal of Clinical Oncology|October 18, 2017
First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intakeHiroki Hara, Shigenori Kadowaki, Masako Asayama, et al.
Pageof 15